Growth Metrics

NovoCure (NVCR) Change in Cash (2016 - 2026)

NovoCure's Change in Cash history spans 13 years, with the latest figure at -$6.1 million for Q1 2026.

  • On a quarterly basis, Change in Cash rose 83.45% to -$6.1 million in Q1 2026 year-over-year; TTM through Mar 2026 was -$32.1 million, a 90.21% increase, with the full-year FY2025 number at -$62.7 million, up 18.0% from a year prior.
  • Change in Cash hit -$6.1 million in Q1 2026 for NovoCure, up from -$241.2 million in the prior quarter.
  • Over the last five years, Change in Cash for NVCR hit a ceiling of $214.8 million in Q1 2024 and a floor of -$288.9 million in Q2 2024.
  • Historically, Change in Cash has averaged -$6.6 million across 5 years, with a median of -$6.1 million in 2026.
  • Biggest five-year swings in Change in Cash: surged 2213.65% in 2024 and later plummeted 944.14% in 2025.
  • Tracing NVCR's Change in Cash over 5 years: stood at -$128.2 million in 2022, then skyrocketed by 167.12% to $86.1 million in 2023, then crashed by 126.85% to -$23.1 million in 2024, then plummeted by 944.14% to -$241.2 million in 2025, then soared by 97.49% to -$6.1 million in 2026.
  • Business Quant data shows Change in Cash for NVCR at -$6.1 million in Q1 2026, -$241.2 million in Q4 2025, and $192.5 million in Q3 2025.